Skip to main content
. 2019 May 14;2(1):43–50. doi: 10.1136/bmjnph-2018-000012

Table 3.

Number (and row percentage) of participants per medication class at baseline and 6 months (n=72)

Medication class at 6 months
Medication class at baseline Baseline No medication Metformin Metformin+SU-derivate Metformin +SU-derivate+Insulin
No medication 7 (10%) 7 0 0 0
Metformin 13 (18%) 2 11 0 0
Metformin+SU-derivate 30 (42%) 5 17 7 1
Metformin+SU-derivate+Insulin 22 (31%) 2 8 1 11
Subtotal 72 (100%) 16 (22%) 36 (50%) 8 (11%) 12 (17%)